Pivotal Research Centers Company Profile

05:49 EDT 20th March 2018 | BioPortfolio

Pivotal Research Centers is one of the largest and most successful clinical research organizations in the nation. Having successfully completed over 450 research studies in over 20 indications, our sites are consistently top-enrolling in numerous studies and consistently delivers high-quality, clean data. Pivotal Research has extensive experience in multiple therapeutic areas with a focus in neurological, psychiatric, and selected internal medicine indications. Pivotal, with it’s unparalleled clinical expertise, thorough regulatory department, state-of-the-art management processes and comprehensive recruitment practices consistently deliver clean, reliable data and rapid patient enrollment.Established in 1993 by Louis C. Kirby, MD, Pivotal Research Centers has grown into five locations; two sites in the Phoenix Metropolitan area (Sun City/Peoria and Mesa), and a site in the metropolitan areas of Detroit, Salt Lake City and Tulsa.


13128 N. 94th Drive Suite 200
United States of America


Phone: (623) 815-9714 ext 251
Fax: (623) 815-9759

News Articles [354 Associated News Articles listed on BioPortfolio]

CSE: 2017-1012 - Delist - Pivotal Therapeutics Inc. (PVO)

TORONTO, ONTARIO -- (Marketwired) -- 10/23/17 -- The common shares of Pivotal Therapeutics Inc. will be delisted at the market close today, October 23, 2017. Pivotal Therapeutics is currently susp...

Smerud Medical Research, Specialists in cost-effective, client-focused and flexible proof-of-concept and pivotal regulatory trials.

Founder and CEO of Smerud Medical Research, Knut Smerud talks to Fintan Walton about the contract research organisation (CRO) company's proof-of-concept clinical trials and pivotal regulatory trials (...

Risankizumab Meets All Primary Endpoints Reporting Positive Results in Fourth Pivotal Phase 3 Psoriasis Study

NORTH CHICAGO, Ill., Dec. 4, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global research and development-based biopharmaceutical company, today announced positive top-line results from IMMhance, the f...

Risankizumab Meets All Co-Primary and Ranked Secondary Endpoints, Achieving Significantly Greater Efficacy Versus Standard Biologic Therapies in Three Pivotal Phase 3 Psoriasis Studies

NORTH CHICAGO, Ill., Oct. 26, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global research and development-based biopharmaceutical company, today announced positive top-line results from three pivotal ...

Regeneron and Sanofi Announce Positive Topline Pivotal Results for PD-1 Antibody Cemiplimab in ...

These pivotal data will form the basis of a rolling Biologics License Application (BLA) submission to the U.S. Food and Drug Administration (FDA), which has Read more...

Revance's RT002 Meets Primary and All Secondary Endpoints, Achieves 6-Month Duration in Pivotal S...

The drug delivered positive top-line results in alleviating moderate-to-severe glabellar lines in two pivotal SAKURA Phase 3 trials.

Australian Research Centers To Receive $1.866 Billion Over Seven-Year Period

Twenty-six Cooperative Research Centers (CRCs) received a new round of funds from the Australian government...

Esperion Releases Top Line Results For First Pivotal Phase 3 Study

Esperion announced positive results for the first in a series of pivotal phase 3 studies of its cholesterol lowering drug.

PubMed Articles [1311 Associated PubMed Articles listed on BioPortfolio]

Argentinean psychiatrists and research. Survey on knowledge, attitudes and practices.

Research in the Mental Health field is essential not only in the academic area, but also in the patient care setting. Knowing the attitudes, knowledge and practices in research among psychiatrists all...

Variation in blood transfusion and coagulation management in Traumatic Brain Injury at the Intensive Care Unit: A survey in 66 neurotrauma centers participating in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study.

Our aim was to describe current approaches and to quantify variability between European intensive care units (ICU)s in patients with TBI. Therefore, we conducted a provider profiling survey as part of...

Implementing an Evidence-based Tobacco Control Program at Five 2-1-1 Call Centers: An Evaluation Using the Consolidated Framework for Implementation Research.

The Smoke-Free Homes Program (SFH) is an evidence-based intervention offered within 2-1-1 information and referral call centers to promote smoke-free homes in low-income populations. We used the Conso...

Partnership Strategies of Community Health Centers: Building Capacity in Good Times and Bad.

Federally Qualified Health Centers--commonly referred to as Community Health Centers (CHCs)--serve as critical safety net providers for those who are uninsured or who may become uninsured. This policy...

Characterizing reduced coverage regions through comparison of exome and genome sequencing data across 10 centers.

PurposeAs massively parallel sequencing is increasingly being used for clinical decision making, it has become critical to understand parameters that affect sequencing quality and to establish methods...

Clinical Trials [2251 Associated Clinical Trials listed on BioPortfolio]

ILLUMENATE Pivotal Post-Approval Study (PAS)

The ILLUMENATE Pivotal PAS is a continued follow-up study which will include 300 subjects from forty-three (43) sites across the United States and Austria previously enrolled in the ILLUME...

A Cohort of Outpatients From French Research Memory Centers in Order to Improve Knowledge on Alzheimer's Disease and Related Disorders

A Multicenter national prospective cohort study including at least 2300 individuals consecutively recruited from French Research Memory Centers and followed-up over 5 years.

ESSENTIAL Trial™ Sham Cross-over

This is a multicenter, un-blinded, open label, pivotal supplemental study to G130163 intended to evaluate the safety and efficacy of treating previous sham subjects in the Essential pivota...

HealthSpark 2: Improving Asthma Care for Preschool Children

From a previous community needs survey, we determined that asthma was a particular problem in our community-based research network of child care centers. This study will examine whether a...

A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With rGBM (GLOBE)

The purpose of this pivotal, phase 3, randomized, multicenter study is to compare VB-111 plus bevacizumab to bevacizumab in adult patients with recurrent GBM.

Companies [2064 Associated Companies listed on BioPortfolio]

Pivotal Research Centers

Pivotal Research Centers is one of the largest and most successful clinical research organizations in the nation. Having successfully completed over 450 research studies in over 20 indications, our si...

Pivotal bioVenture Partners

Pivotal bioVenture Partners is a San Francisco-based venture capital firm investing in early stage biotechnology companies. Pivotal closed on $300 million for their first fund and...

Pivotal Therapeutics Inc.

With offices in Toronto, Canada and Boca Raton, Florida, Pivotal Therapeutics is a publicly traded (OTCQX: PVTTF; CNSX: PVO) specialty pharmaceutical company with a focus on cardi...

Pivotal Research/Premier Research

KOP Research Centre Pvt. Ltd.

KOP Research Centre is the outcome of vision of Kumar Organic Products. At KRC we are firmly committed to our vision of progress through Research and Development with a Global Mindset, of setting glob...

More Information about "Pivotal Research Centers" on BioPortfolio

We have published hundreds of Pivotal Research Centers news stories on BioPortfolio along with dozens of Pivotal Research Centers Clinical Trials and PubMed Articles about Pivotal Research Centers for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pivotal Research Centers Companies in our database. You can also find out about relevant Pivotal Research Centers Drugs and Medications on this site too.

Quick Search


Relevant Topic

Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Corporate Database Quicklinks

Searches Linking to this Company Record